PharmaOPS.BXL
The computed 12-month bankruptcy probability of PharmaOPS.BXL is 7.3% (elevated). The 2024 annual accounts show equity of €6k and a net result of €5k. Its solvency ranks better than 20% of 1220 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €6k |
| Net result | €5k |
| Staff (FTE) | 6.1 |
| Better than sector | 20% |
Strong profile, led by profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 0.2% | 20.4% | |
| Net result | €5k | €26k | |
| Equity | €6k | €143k | |
| Gross operating margin | €596k | €217k | |
| Staff costs | €333k | €163k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €236k |
| Net profit | €5k |
| Cash flow | €151k |
| Staff costs | €333k |
| Income taxes | €550 |
| Dividends | - |
| Total assets | €3.56M |
| Equity | €6k |
| Debt | €3.55M |
| of which ≤ 1y | €965k |
| of which > 1y | €2.36M |
| Working capital | €-135k |
| Employees (FTE) | 6.1 |
| 2024 | |
|---|---|
| Current ratio | 0.86 |
| Quick ratio | 0.44 |
| Working capital ratio | -3.8% |
| Solvency | 0.2% |
| Debt / equity | 566.88 |
| Long-term debt ratio | 376.75 |
| Interest coverage | 2.64 |
| Gross margin | - |
| Net margin | - |
| ROA | 0.1% |
| ROE | 84.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €3.56M |
| Fixed assets | 21/28 | €2.73M |
| Intangible fixed assets | 21 | €1.41M |
| Tangible fixed assets | 22/27 | €99k |
| Financial fixed assets | 28 | €1.22M |
| Current assets | 29/58 | €831k |
| Stocks & contracts in progress | 3 | €404k |
| Amounts receivable within one year | 40/41 | €297k |
| Cash & bank | 54/58 | €123k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €3.56M |
| Equity | 10/15 | €6k |
| Contributions / capital | 10/11 | €1k |
| Accumulated profits (losses) | 14 | €5k |
| Amounts payable | 17/49 | €3.55M |
| Amounts payable after one year | 17 | €2.36M |
| Amounts payable within one year | 42/48 | €965k |
| Trade debts payable within one year | 44 | €498k |
| Income statement | ||
| Gross operating margin | 9900 | €596k |
| Operating result | 9901 | €90k |
| Financial income | 75 | €5k |
| Financial charges | 65 | €89k |
| Result before taxes | 9903 | €6k |
| Income taxes | 67/77 | €550 |
| Net result for the period | 9904 | €5k |
| Result to be appropriated | 9905 | €5k |
-
Current01-10-2025 → present
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 17-08-2023 |
| Status | Active |
| Postal code | 1000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21383B0071/00B006 | Brussels | 450 m² | 1 · 450 m² | 23.9 m · 7 fl. |
| 21342B0108/00W005 | Brussels | 300 m² | 1 · 152 m² | 14.7 m · 4 fl. |
| 21612C0056/02B086 | Brussels | 225 m² | 1 · 99 m² | 16.1 m · 4 fl. |
| 21803C0405/00H000 | Brussels | 211 m² | 1 · 172 m² | 22.4 m · 6 fl. |
| 22662B0375/00R006 | Flanders | 148 m² | 1 · 83 m² | 13.3 m · 4 fl. |
| 21803C1594/00Z000 | Brussels | 136 m² | - | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
13-04-2026 Act object · General meeting · Permanent representative
- Filing: 2026-04-03 · PHARMACIE BOTANIQUE
- Publication: 2026-04-13 · PHARMACIE BOTANIQUE
- Act object: Constatation changement représentant permanent · PHARMACIE BOTANIQUE
- General meeting: 2026-02-13 · PHARMACIE BOTANIQUE
- Permanent representative: role: représentant permanent, start_date: 2025-12-12 · Georges DE FEU
- Permanent representative: role: ancien représentant permanent, end_date: 2025-12-12 · Olivier OLBRECHTS
Technical details
{
"facts": [
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 / Re\u00E7u le U 3 AVR. 2026",
"value": "2026-04-03",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 13/04/2026 - Annexes du Moniteur belge",
"value": "2026-04-13",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Constatation changement repr\u00E9sentant permanent",
"value": "Constatation changement repr\u00E9sentant permanent",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Extrait du proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale tenue le 13/02/2026",
"value": "2026-02-13",
"object": null,
"subject": "e1"
},
{
"type": "permanent_representative",
"quote": "L\u0027assembl\u00E9e constate que la soci\u00E9t\u00E9-administrateur, SRL \u003C PharmaOPS.BXL \u00BB (num\u00E9ro d\u0027entreprise 0804.644.494), est repr\u00E9sent\u00E9e par Monsieur Georges DE FEU en qualit\u00E9 de repr\u00E9sentant permanent, \u00E0 compter du 12/12/2025",
"value": {
"role": "repr\u00E9sentant permanent",
"start_date": "2025-12-12"
},
"object": "e2",
"subject": "e3"
},
{
"type": "permanent_representative",
"quote": "et non plus par Monsieur Olivier OLBRECHTS.",
"value": {
"role": "ancien repr\u00E9sentant permanent",
"end_date": "2025-12-12"
},
"object": "e2",
"subject": "e4"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1580,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0473.905.772",
"kind": "company",
"name": "PHARMACIE BOTANIQUE",
"attrs": {
"address": "Boulevard du Jardin Botanique 36, 1000 Bruxelles",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e2",
"kbo": "0804.644.494",
"kind": "company",
"name": "PharmaOPS.BXL",
"attrs": {
"role": "soci\u00E9t\u00E9-administrateur",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Georges DE FEU",
"attrs": {
"role": "repr\u00E9sentant permanent"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Olivier OLBRECHTS",
"attrs": {
"role": "ancien repr\u00E9sentant permanent"
}
}
]
}13-04-2026 Act object · General meeting · Officer resignation · Officer discharge
- Filing: 2026-04-03 · PharmaOPS.BXL
- Publication: 2026-04-13 · PharmaOPS.BXL
- Act object: Démission administrateur - Constatation changement représentant permanent · PharmaOPS.BXL
- General meeting: 2026-02-13 · PharmaOPS.BXL
- Officer resignation: role: administrateur, effective_date: 2025-12-12 · Georges DE FEU
- Officer discharge · Georges DE FEU
- Permanent representative: role: représentant permanent, for_company: PharmaOPS.BXL, effective_date: 2025-12-12 · Georges DE FEU
- Permanent representative: role: représentant permanent, status: ceased, for_company: PharmaOPS.BXL, effective_date: 2025-12-12 · Olivier OLBRECHTS
Technical details
{
"facts": [
{
"type": "filing",
"quote": "U 3 AVR. 2026",
"value": "2026-04-03",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "13/04/2026",
"value": "2026-04-13",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: D\u00E9mission administrateur - Constatation changement repr\u00E9sentant permanent",
"value": "D\u00E9mission administrateur - Constatation changement repr\u00E9sentant permanent",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Extrait du proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale tenue le 13/02/2026",
"value": "2026-02-13",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "L\u0027assembl\u00E9e a pris acte de la d\u00E9mission en tant qu\u0027administrateur, offerte volontairement avec effet au 12/12/2025, par Monsieur Georges DE FEU.",
"value": {
"role": "administrateur",
"effective_date": "2025-12-12"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_discharge",
"quote": "L\u0027approbation des comptes annuels de l\u0027exercice \u00E9coul\u00E9 vaudra d\u00E9charge pour l\u0027exercice de son mandat.",
"value": null,
"object": "e1",
"subject": "e2"
},
{
"type": "permanent_representative",
"quote": "L\u0027assembl\u00E9e constate que la soci\u00E9t\u00E9-administrateur, SRL \u003C PharmaBXL \u00BB (num\u00E9ro d\u0027entreprise 0795.508.480), est repr\u00E9sent\u00E9e par Monsieur Georges DE FEU en qualit\u00E9 de repr\u00E9sentant permanent, \u00E0 compter du 12/12/2025, pour l\u0027exercice de son mandat d\u0027administration au sein de notre soci\u00E9t\u00E9 (SRL \u003C PharmaOPS.BXL \u003E)",
"value": {
"role": "repr\u00E9sentant permanent",
"for_company": "PharmaOPS.BXL",
"effective_date": "2025-12-12"
},
"object": "e3",
"subject": "e2"
},
{
"type": "permanent_representative",
"quote": "et non plus par Monsieur Olivier OLBRECHTS.",
"value": {
"role": "repr\u00E9sentant permanent",
"status": "ceased",
"for_company": "PharmaOPS.BXL",
"effective_date": "2025-12-12"
},
"object": "e3",
"subject": "e4"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1967,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0804.644.494",
"kind": "company",
"name": "PharmaOPS.BXL",
"attrs": {
"seat": "Avenue Albert 154, 1190 Forest",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Georges DE FEU",
"attrs": {}
},
{
"id": "e3",
"kbo": "0795.508.480",
"kind": "company",
"name": "PharmaBXL",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Olivier OLBRECHTS",
"attrs": {}
}
]
}12-11-2025 Georges DE FEU appointed as director
- Georges DE FEU, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Georges DE FEU",
"address": null,
"birth_date": null
},
"effective_date": "2025-10-01",
"evidence_quote": "De nommer Monsieur Georges DE FEU, domicili\u00E9 rue Bosquet 50/03 \u00E0 1060 Saint Gilles en tant qu\u0027administrateur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0804.644.494",
"name_full": "PHARMAOPS.BXL",
"legal_form": "SRL"
}
}21-08-2023 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1190 Forest, Avenue Albert 154",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0795.508.480",
"name": "PHARMABXL"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "A",
"partner_role": null,
"holder_org_kbo": "0795.508.480",
"holder_org_name": "PHARMABXL",
"contribution_type": "cash",
"amount_paid_in_eur": 900,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 900000,
"amount_subscribed_eur": 900,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0465.400.159",
"name": "FILIP GILIAS"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "B",
"partner_role": null,
"holder_org_kbo": "0465.400.159",
"holder_org_name": "FILIP GILIAS",
"contribution_type": "cash",
"amount_paid_in_eur": 12.296,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 12296,
"amount_subscribed_eur": 12.296,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0894.633.869",
"name": "REMEDIA"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "B",
"partner_role": null,
"holder_org_kbo": "0894.633.869",
"holder_org_name": "REMEDIA",
"contribution_type": "cash",
"amount_paid_in_eur": 13.489,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 13489,
"amount_subscribed_eur": 13.489,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0541.432.719",
"name": "PHARMALEGAL"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "B",
"partner_role": null,
"holder_org_kbo": "0541.432.719",
"holder_org_name": "PHARMALEGAL",
"contribution_type": "cash",
"amount_paid_in_eur": 49.623,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 49623,
"amount_subscribed_eur": 49.623,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0844.823.280",
"name": "O2C"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "B",
"partner_role": null,
"holder_org_kbo": "0844.823.280",
"holder_org_name": "O2C",
"contribution_type": "cash",
"amount_paid_in_eur": 24.592,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 24592,
"amount_subscribed_eur": 24.592,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 1000,
"subject_company": {
"kbo": "0804.644.494",
"name_full": "PharmaOPS.BXL",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2023-08-07",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PharmaOPS.BXL |